A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology

Abstract : We present in this paper a new mathematical model designed to optimize and to rationalize the association between cytotoxic and antiangiogenic drugs in the treatment of a primary tumor. This model takes into account the non-linear interlinkings between both drugs. In particular, this original model integrates the influence of the vasculature state on the delivery of the drugs to the tumor. In the future, this model could be used in clinical oncology to optimize antiangiogenic-based combinational regimen so as to ensure a maximum efficacy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [14 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-00641476
Contributor : Florence Hubert <>
Submitted on : Monday, February 6, 2012 - 10:19:02 AM
Last modification on : Thursday, May 9, 2019 - 1:40:17 PM
Long-term archiving on : Wednesday, December 14, 2016 - 3:38:56 AM

File

cras_2011_newnew_hal_v2.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Sébastien Benzekry, Guillemette Chapuisat, Joseph Ciccolini, Alice Erlinger, Florence Hubert. A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology. Comptes rendus de l'Académie des sciences. Série I, Mathématique, Elsevier, 2012, 350, pp.23-28. ⟨10.1016/j.crma.2011.11.019⟩. ⟨hal-00641476v2⟩

Share

Metrics

Record views

646

Files downloads

363